Imaging for evaluating dementia and Alzheimer's Disease
Until recently, there were very few treatment options for dementia syndromes such as Alzheimer’s disease. But recent breakthroughs have resulted in new drug and non-drug possibilities that may yield many positive outcomes. As they continue to learn about changes in the brain, medical experts are cautious but hopeful about developing treatments that can stop or delay the progression of Alzheimer’s. Understanding available options can help individuals living with the disease and their caregivers navigate symptoms and improve quality of life, which is why it’s more important than ever to detect those symptoms as early as possible.
1. Alzheimer's Association. 2021 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 2021. www.alz.org/alzheimers-dementia/facts-figures. Accessed April 13, 2021.
Amyloid PET radio pharmaceutical is a radioactive diagnostic agent indicated for PET imaging of the brain to estimate ß-amyloid neuritic plaque density in adult patients with cognitive impairment.
Scheduling: 505-998-5925
Fax : 505-323-4331
Scheduling: 505-998-5925
Fax : 505-323-4331